The Medical and Surgical Practice of NaProTECHNOLOGY, 677-696, 2004
Chapter 51: Effectiveness of NaProTECHNOLOGY
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
Cumulative pregnancy and live birth data from the Pope Paul VI Institute document NaProTECHNOLOGY outcomes across diagnostic categories including unexplained infertility, endometriosis, PCOD, and tubal disease, with multi-year follow-up that captures pregnancies occurring after continued treatment — a metric not captured in per-cycle ART statistics. These outcomes provide the evidence base for positioning NaProTECHNOLOGY as a first-line rather than last-resort reproductive medicine strategy.
Topics
Cite this article
Hilgers, T. W. (2004). Chapter 51: Effectiveness of NaProTECHNOLOGY. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 677-696.
Hilgers TW. Chapter 51: Effectiveness of NaProTECHNOLOGY. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:677-696.
Hilgers, T. W. "Chapter 51: Effectiveness of NaProTECHNOLOGY." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 677-696.